[go: up one dir, main page]

MX2009013725A - Composiciones de fragmentos de tejido para el tratamiento de la incontinencia. - Google Patents

Composiciones de fragmentos de tejido para el tratamiento de la incontinencia.

Info

Publication number
MX2009013725A
MX2009013725A MX2009013725A MX2009013725A MX2009013725A MX 2009013725 A MX2009013725 A MX 2009013725A MX 2009013725 A MX2009013725 A MX 2009013725A MX 2009013725 A MX2009013725 A MX 2009013725A MX 2009013725 A MX2009013725 A MX 2009013725A
Authority
MX
Mexico
Prior art keywords
treatment
incontinence
compositions
tissue fragment
fragment compositions
Prior art date
Application number
MX2009013725A
Other languages
English (en)
Inventor
Anna Gosiewska
Agnieszka Seyda
Charito S Buensuceso
Sridevi Dhanaraj
Original Assignee
Ethicon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ethicon Inc filed Critical Ethicon Inc
Publication of MX2009013725A publication Critical patent/MX2009013725A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/34—Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3641—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the site of application in the body
    • A61L27/367—Muscle tissue, e.g. sphincter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3641—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the site of application in the body
    • A61L27/3679—Hollow organs, e.g. bladder, esophagus, urether, uterus, intestine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Botany (AREA)
  • Vascular Medicine (AREA)
  • Transplantation (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)

Abstract

Se describen composiciones para el tratamiento de la incontinencia. En particular, se describen las composiciones de fragmentos de tejido muscular viable y un portador. Las composiciones sirven para el tratamiento de la incontinencia urinaria y fecal.
MX2009013725A 2007-06-15 2008-06-05 Composiciones de fragmentos de tejido para el tratamiento de la incontinencia. MX2009013725A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US94426607P 2007-06-15 2007-06-15
PCT/US2008/065894 WO2008157059A1 (en) 2007-06-15 2008-06-05 Tissue fragment compositions for the treatment of incontinence

Publications (1)

Publication Number Publication Date
MX2009013725A true MX2009013725A (es) 2010-01-25

Family

ID=39797924

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009013725A MX2009013725A (es) 2007-06-15 2008-06-05 Composiciones de fragmentos de tejido para el tratamiento de la incontinencia.

Country Status (12)

Country Link
US (1) US20080311219A1 (es)
EP (1) EP2155216A1 (es)
JP (1) JP2010529888A (es)
CN (1) CN101678049A (es)
AU (1) AU2008266311A1 (es)
BR (1) BRPI0813352A2 (es)
CA (1) CA2691361A1 (es)
IL (1) IL202256A0 (es)
MX (1) MX2009013725A (es)
RU (1) RU2459627C2 (es)
WO (1) WO2008157059A1 (es)
ZA (1) ZA201000279B (es)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102123745A (zh) 2008-02-29 2011-07-13 科洛普拉斯特公司 用于受试者中活组织的增加和再生的组合物和方法
DE102009021003A1 (de) * 2009-05-12 2010-11-18 Centrotherm Sitec Gmbh Verfahren und Vorrichtung zur Bereitstellung flüssigen Siliziums
US20120165957A1 (en) * 2009-07-06 2012-06-28 Hanne Everland Biodegradable scaffold for soft tissue regeneration and use thereof
US8337415B2 (en) * 2010-02-22 2012-12-25 Devicor Medical Products, Inc. Tissue harvesting, mincing, and transport device
US8535239B2 (en) 2010-05-11 2013-09-17 Ethicon Endo-Surgery, Inc. Tissue harvesting device with manual dicing mechanism
US8464925B2 (en) * 2010-05-11 2013-06-18 Ethicon Endo-Surgery, Inc. Methods and apparatus for delivering tissue treatment compositions to stapled tissue
US8641641B2 (en) 2010-05-11 2014-02-04 Ethicon Endo-Surgery, Inc. Instrument for applying therapeutic cells, with proximal portion for processing therapeutic cells
US8974400B2 (en) 2010-05-11 2015-03-10 Ethicon Endo-Surgery, Inc. Instrument for applying therapeutic cells, with distal portion for processing therapeutic cells
US8349255B2 (en) 2010-05-11 2013-01-08 Ethicon Endo-Surgery, Inc. Tissue processing system and method
US8286899B2 (en) 2010-05-11 2012-10-16 Ethicon Endo-Surgery, Inc. Tissue dicing and particle separation device
US9138210B2 (en) 2010-05-11 2015-09-22 Ethicon Endo-Surgery, Inc. Fistula cleaning and repair device and method
US8646674B2 (en) 2010-05-11 2014-02-11 Ethicon Endo-Surgery, Inc. Methods and apparatus for delivering tissue treatment compositions to stapled tissue
US8468891B2 (en) 2010-05-12 2013-06-25 Ethicon Endo-Surgery, Inc. Tissue processing device with ultrasonic measuring chamber
US8986331B2 (en) 2010-05-12 2015-03-24 Ethicon Endo-Surgery, Inc. Instrument for debriding fistula and applying therapeutic cells
US20110282368A1 (en) 2010-05-12 2011-11-17 Swayze Jeffrey S Fistula Repair Device with Extendable Barbs and Therapeutic Cell Delivery
US8714360B2 (en) 2010-05-12 2014-05-06 Ethicon Endo-Surgery, Inc. Tissue processing device with ultrasonic tissue particle separator
US8858546B2 (en) 2010-05-12 2014-10-14 Ethicon Endo-Surgery, Inc. Instrument for debriding fistula and applying therapeutic cells
US8491526B2 (en) 2010-05-13 2013-07-23 Ethicon Endo-Surgery, Inc. Therapeutic cell applicator instrument with modular tips
US8702644B2 (en) 2010-05-13 2014-04-22 Ethicon Endo-Surgery, Inc. Instrument for debriding tissue and applying therapeutic cells
US8568446B2 (en) 2010-05-13 2013-10-29 Ethicon Endo-Surgery, Inc. Multi-chamber therapeutic cell applicator instrument
US8486155B2 (en) 2010-05-13 2013-07-16 Ethicon Endo-Surgery, Inc. Fistula repair plug having multiple layers
US8491497B2 (en) 2010-05-13 2013-07-23 Ethicon Endo-Surgery, Inc. Method and apparatus for morcellating tissue
JP6196217B2 (ja) * 2011-08-17 2017-09-13 ウェイク・フォレスト・ユニヴァーシティ・ヘルス・サイエンシズ 筋線維断片を利用した筋組織再生
RU2539188C1 (ru) * 2013-06-25 2015-01-20 Краевое государственное бюджетное образовательное учреждение дополнительного профессионального образования "ИНСТИТУТ ПОВЫШЕНИЯ КВАЛИФИКАЦИИ СПЕЦИАЛИСТОВ ЗДРАВООХРАНЕНИЯ" (КГБОУ ДПО ИПКСЗ) Способ лечения энкопреза
EP3139945B1 (en) * 2014-05-08 2025-08-27 Wake Forest University Health Sciences Methods of treating incontinence and other sphincter deficiency disorders
US10159971B2 (en) * 2015-05-03 2018-12-25 Clear Labs Inc. Apparatus and method for economic, fast and easy sampling of food and environmental samples
RU2629528C2 (ru) * 2015-11-12 2017-08-29 Антон Юрьевич Цуканов Способ создания модели для изучения эффектов введения объем-образующих веществ у лабораторных животных
CA3153074A1 (en) * 2019-10-24 2021-04-29 Anthony Atala Rotator cuff therapy using muscle fiber fragments
EP4304667B1 (en) * 2021-03-16 2024-07-10 Aalto University Foundation sr A composition for use in the treatment of urinary or faecal incontinence

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4803075A (en) * 1986-06-25 1989-02-07 Collagen Corporation Injectable implant composition having improved intrudability
US5130141A (en) * 1988-05-24 1992-07-14 Law Peter K Compositions for and methods of treating muscle degeneration and weakness
US5116387A (en) * 1989-06-09 1992-05-26 American Medical Systems, Inc. Preparation of injectable polymeric bodies
US5158573A (en) * 1989-06-09 1992-10-27 American Medical Systems, Inc. Injectable polymeric bodies
US5007940A (en) * 1989-06-09 1991-04-16 American Medical Systems, Inc. Injectable polymeric bodies
US5538722A (en) * 1989-06-13 1996-07-23 Stanford University Isolation, growth, differentiation and genetic engineering of human muscle cells
US5709854A (en) * 1993-04-30 1998-01-20 Massachusetts Institute Of Technology Tissue formation by injecting a cell-polymeric solution that gels in vivo
AU684796B2 (en) * 1993-04-30 1998-01-08 Children's Medical Center Corporation Injectable polysaccharide-cell compositions
US5451406A (en) * 1994-07-14 1995-09-19 Advanced Uroscience, Inc. Tissue injectable composition and method of use
US5964805A (en) * 1997-02-12 1999-10-12 Stone; Kevin R. Method and paste for articular cartilage transplantation
US6866842B1 (en) * 1998-05-01 2005-03-15 University Of Pittsburgh Muscle-derived cells (MDCs) for treating muscle-or bone-related injury or dysfunction
DE69939956D1 (de) * 1998-05-01 2009-01-02 Univ Pittsburgh Verwendung von Myoblasten zur Herstellung eines Medikaments zur Behandlung der stressbedingten Harninkontinenz
US7338657B2 (en) * 2001-03-15 2008-03-04 Biosphere Medical, Inc. Injectable microspheres for tissue construction
KR100494265B1 (ko) * 2001-08-14 2005-06-13 메디포스트(주) 관절연골손상 치료용 조성물
CA2485567A1 (en) * 2002-05-10 2003-11-20 Isolagen Technologies, Inc. Treatments with autologous fibroblast
US20040078090A1 (en) * 2002-10-18 2004-04-22 Francois Binette Biocompatible scaffolds with tissue fragments
US7115100B2 (en) * 2002-11-15 2006-10-03 Ethicon, Inc. Tissue biopsy and processing device
MXPA05006350A (es) * 2002-12-13 2006-02-08 Celogos Composicion de medio de cultivo, procedimiento de cultivo y mioblastos obtenidos y sus utilizaciones.
US7316822B2 (en) * 2003-11-26 2008-01-08 Ethicon, Inc. Conformable tissue repair implant capable of injection delivery
US8715733B2 (en) * 2004-07-23 2014-05-06 DePuy Synthes Products, LLC Enhanced adipose tissue
JP2009506805A (ja) * 2005-09-02 2009-02-19 コンティネンス コントロール システムズ インターナショナル プロプライエタリー リミテッド 病状を管理するための平滑筋インプラント
US20070065415A1 (en) * 2005-09-16 2007-03-22 Kleinsek Donald A Compositions and methods for the augmentation and repair of defects in tissue

Also Published As

Publication number Publication date
CA2691361A1 (en) 2008-12-24
RU2459627C2 (ru) 2012-08-27
JP2010529888A (ja) 2010-09-02
AU2008266311A1 (en) 2008-12-24
ZA201000279B (en) 2011-03-30
EP2155216A1 (en) 2010-02-24
CN101678049A (zh) 2010-03-24
WO2008157059A1 (en) 2008-12-24
US20080311219A1 (en) 2008-12-18
IL202256A0 (en) 2010-06-16
BRPI0813352A2 (pt) 2014-12-30
RU2010101082A (ru) 2011-07-20

Similar Documents

Publication Publication Date Title
MX2009013725A (es) Composiciones de fragmentos de tejido para el tratamiento de la incontinencia.
ATE502599T1 (de) Maschenimplantat
MX368173B (es) Una composición farmacéutica que comprende una proteína de fusión actriia-fc expresada de células cho.
WO2011005493A3 (en) Methods and materials for tissue repair
MX2009013726A (es) Composiciones de celulas derivadas de tejido umbilical humano para el tratamiento de la incontinencia.
AU2013207611A1 (en) Surgical implants, tools, and methods for treating pelvic conditions
TW200806298A (en) Methods for modulating bladder function
WO2005122727A3 (en) Systems and methods for bilateral stimulation of left and right branches of the dorsal genital nerves to treat dysfunctions, such as urinary incontinence
MX344786B (es) Composiciones y metodos para tratar enfermedad de gaucher.
IN2012DN02046A (es)
IL233634A0 (en) Methods, compositions and kits for treating medical conditions
MX2008011633A (es) Aminoquinolonas como inhibidores de gsk-3.
MX2009003362A (es) Uso de interleucina-10 pegilada para tratamiento de cancer.
IL190796A0 (en) Compositions and their uses for gene therapy of bone conditions
TW200738262A (en) Methods for preventing and treating cancer metastasis and bone loss associated with cancer metastasis
EP1879578A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF URINARY INCONTINENCE
WO2010088450A3 (en) Arylamide derivatives useful in the treatment of diseases associated with serca activity
EP2425849A3 (en) Compositions and methods using anti-CS1 antibodies to treat multiple myeloma
NZ579478A (en) Epha3 antibodies for the treatment of solid tumors
TW200716106A (en) Methods for modulating bladder function
CA2659376C (en) 2,4-diaminoquinazolines for spinal muscular atrophy
EP1868435A4 (en) COMBINATIONS, METHODS AND COMPOSITIONS FOR TREATING CANCER
MX2009003022A (es) Composiciones y metodos para tratar picaduras de medusa.
TW200716088A (en) Formulations and methods for treating amyloidosis
EP1968645A4 (en) HUMAN GLP-1 MIMETIC BODIES AND COMPOSITIONS FOR THE TREATMENT OF ADIPOSITAS AND RELATED DISEASES, METHODS AND APPLICATIONS

Legal Events

Date Code Title Description
HH Correction or change in general
FG Grant or registration